Daminova KM*, Abduqodirova ShA and Xusanxojaeva FT

Tashkent State Dental Institute, Uzbekistan

*Corresponding Author: Daminova KM, Tashkent State Dental Institute, Uzbekistan.

Received: December 28, 2022; Published: January 27, 2023

Abstract

All patients conducted an explanation about monitoring the level of blood pressure in the form of self-control to assess its influence on the development of CKD, and also determined intrauditive and long-term variability (LTV). Due to the study, the presence of arterial hypertension is recorded as a risk factor for the progression of chronic kidney disease in the absence of clinical manifestations, the data indicate the need to study arterial hypertension as a risk factor for the development and progression of CKD during the initial examination of patients. In the early diagnosis of risk factors, normalization of the level of HTN, and the achievement of target blood pressure numbers is more effective.

Keywords: Chronic Kidney Disease; Arterial Hypertension; Primary Link; Progression; Intrauditive Variability; Long-term Variability; Prevention; Risk Factors

References

1. Arutyunov GP. “Problems of nephroprotection in patients with arterial hypertension. The value of the microalbuminuria indicator for a general practitioner”. Quality of life. The medicine. Diseases of the cardiovascular system: arterial hypertension 3 (2005): 2-7.
2. Arutyunov GP., et al. “The tubulo-stust apparatus of the kidney and its lesion for arterial hypertension”. Clinical Nephrology 1 (2011): 52-57.
3. Borovkova NYu., et al. “School of the patient as an important factor in improving adherence to treatment in patients with renoparenchymal arterial hypertension”. Wedge Nephrology 2 (2011): 40-44.
4. Borkum M., et al. “Ambulatory blood pressure profiles in a subset of HIV-positive patients pre and post antiretroviral therapy”. Cardiovascular Journal of Africa 4 (2014): 153-157.
5. M Rahman., et al. “Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate”. Annals of Internal Medicine3 (2011): 172-180.
6. HTNmed SB and Dumanski SM. “Why Do Patients With Well-Controlled Vascular Risk Factors Develop Progressive Chronic Kidney Disease?” Canadian Journal of Cardiology9 (2016): 1170-1180.
7. Daminova KM., et al. “Some factors for the development and progression of chronic kidney disease in a primary line of health care”. Chinese Journal of Industrial Hygiene and Occupational Diseases 7 (2021): 59-62.
8. Daminova KM., et al. “The significance of CKD risk factors in its progression at the level of primary health care”. British Medical Journal 1 (2022): 180-185
9. Di Daniele N., et al. “Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease”. Atherosclerosis 267 (2017): 139-145.
10. Gaitonde DY., et al. “Chronic Kidney Disease: Detection and Evaluation”. American Family Physician12 (2017): 776-783.
11. Kutyrina IM., et al. “Arterial hypertension in chronic glomerulonephritis: frequency of detection and effectiveness of treatment”. TER. Archive. No. 9, 10-5.
12. Kataoka H., et al. “A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression”. Kidney and Blood Pressure Research3 (2019): 362-383.
13. “KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)”. Official Journal of the International Society of Nephrology1 (2017).
14. Konradi AO., et al. “Educating hypertensive patients - a waste of time or a real tool in improving the quality of disease control? Consilium-medicum”. Arterial Hypertension6 (2002).
15. RHTNman M., et al. “Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study”. Journal of the American Society of Nephrology 11 (2020): 2609-2621.
16. Vyalkina NA., et al. “Features of the daily profile of blood pressure and its effect on the outcome in patients with chronic kidney disease receiving software hemodialysis”. Therapy2 (2019): 19-23.
17. Shih CC., et al. “Risk Prediction for Early Chronic Kidney Disease: Results from an Adult Health Examination Program of 19,270 Individuals”. International Journal of Environmental Research and Public Health 14 (2020): 4973.
18. Weir M. “Recognition and Management of a Less Common Cause of Chronic Kidney Disease: Autosomal Dominant Polycystic Kidney Disease”. Journal of Family Practice 7 (2020): S57-S62.
19. Wheiton PK., et al. “2017 ACC/HTNA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. Hypertension6 (2018): 1269-1324.

Citation

Citation: Daminova KM., et al. “The Daily Profile of Blood Pressure in Patients with CKD of Various Stages”.Acta Scientific Medical Sciences 7.2 (2023): 154-159.

Copyright

Copyright: © 2022 Daminova KM., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.